• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION AVALUS AORTIC TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION AVALUS AORTIC TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 40025
Device Problems Gradient Increase (1270); Patient Device Interaction Problem (4001); Device Stenosis (4066); Central Regurgitation (4068)
Patient Problems Aneurysm (1708); Aortic Valve Stenosis (1717); Thrombosis/Thrombus (4440); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 10/26/2023
Event Type  Injury  
Event Description
Medtronic received information that 9 years post implant of this 25mm aortic bioprosthetic valve, non-obstructive valve thrombosis was observed.It was stated that the aortic mean gradient increased to 31 mmhg.Further examination via computed tomography (ct) discovered mild thickened and kinked leaflets.No additional adverse patient effects were reported.It was later reported that a transthoracic echocardiogram (tte) performed 5 months later showed moderate to severe aortic stenosis (as) and severe aortic regurgitation (ar).It was also stated that a aneurysm of the ascending aorta was observed.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic received information that 9 years post implant of this 25mm aortic bioprosthetic valve, non-obstructive valve thrombosis was observed.It was stated that the aortic mean gradient increased to 31 mmhg.Further examination via computed tomography (ct) discovered mild thickened and kinked leaflets.No additional adverse patient effects were reported.It was later reported that a transthoracic echocardiogram (tte) performed 5 months later showed moderate to severe aortic stenosis (as) and severe aortic regurgitation (ar).It was also stated that a aneurysm of the ascending aorta was observed.It was indicated that the aneurysm measures 48mm.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Corrected b5 to include "it was indicated that the aneurysm measures 48mm." medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVALUS AORTIC TISSUE VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18985760
MDR Text Key338693216
Report Number2025587-2024-01930
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P170006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/22/2015
Device Model Number40025
Device Catalogue Number40025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/22/2024
Date Device Manufactured08/22/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age72 YR
Patient SexMale
Patient Weight104 KG
-
-